Skip to main content
Erschienen in:

06.11.2019 | Original Article

Delayed diagnosis of congenital hypopituitarism associated with low socio-economic status and/or migration

verfasst von: Emese Boros, Madeleine Casimir, Claudine Heinrichs, Cécile Brachet

Erschienen in: European Journal of Pediatrics | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

The clinical presentation of combined pituitary hormone deficiency (CPHD) is variable. Some patients present with hypoglycemia during the neonatal period or during the first few years of life. Others present later in childhood with growth failure. We report on 7 patients with very late diagnosed severe hypopituitarism with pituitary stalk interruption syndrome. Five out of the 7 patients had recently migrated to Belgium and the 2 other patients were from low socio-economic status families. All of them presented to our clinic for short stature and some also complained of lack of pubertal development. Four out of the 7 patients reached final height which was within their target height, despite very delayed treatment.
Conclusion: We illustrate the overall good outcome of these children with delayed diagnosed severe hypopituitarism. Adverse life conditions and social deprivation are thought to be the cause of their late diagnosis. In the current global socio-politic context, pediatricians in high-income countries should stay aware that migration and poor socio-economic status can be associated with specific clinical presentations.
What is Known:
• The clinical presentation of combined pituitary hormone deficiency (CPHD) is variable. Some patients present with hypoglycemia during the neonatal period or during the first few years of life. Others present later in childhood with growth failure.
• A few case reports are published with very late diagnosis of congenital hypopituitarism.
What is New:
• We report on the largest series of delayed diagnosis of congenital hypopituitarism and illustrate the survival of these children with overall good prognosis.
• Migration and social deprivation are thought to be the main cause of this late diagnosis.
Literatur
1.
Zurück zum Zitat Arrigo T, Crisafulli G, Salamone A, Cucinotta D, de Luca F (1994) Adult height exceeding target height in a patient with congenital panhypopituitarism diagnosed after the age of 25 years. J Pediatr Endocrinol 7:269–272CrossRef Arrigo T, Crisafulli G, Salamone A, Cucinotta D, de Luca F (1994) Adult height exceeding target height in a patient with congenital panhypopituitarism diagnosed after the age of 25 years. J Pediatr Endocrinol 7:269–272CrossRef
2.
Zurück zum Zitat Badawy SZ, Pisarska MD, Wasenko JJ, Buran JJ (1994) Congenital hypopituitarism as part of suprasellar dysplasia. A case report. J Reprod Med 39:643–648PubMed Badawy SZ, Pisarska MD, Wasenko JJ, Buran JJ (1994) Congenital hypopituitarism as part of suprasellar dysplasia. A case report. J Reprod Med 39:643–648PubMed
5.
Zurück zum Zitat Grumbach MM (2005) A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J Clin Endocrinol Metab. 90(5):3122–3127CrossRef Grumbach MM (2005) A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J Clin Endocrinol Metab. 90(5):3122–3127CrossRef
6.
Zurück zum Zitat Jain V, Kannan L, Kumar P (2011) Congenital hypopituitarism presenting as dilated cardiomyopathy in a child. J Pediatr Endocrinol Metab JPEM 24:767–769PubMed Jain V, Kannan L, Kumar P (2011) Congenital hypopituitarism presenting as dilated cardiomyopathy in a child. J Pediatr Endocrinol Metab JPEM 24:767–769PubMed
7.
Zurück zum Zitat Kageyama K, Watanobe H, Nasushita R et al (1998) A hypopituitary patient who attained tall stature without growth hormone. Intern Med Tokyo Jpn 37:472–475CrossRef Kageyama K, Watanobe H, Nasushita R et al (1998) A hypopituitary patient who attained tall stature without growth hormone. Intern Med Tokyo Jpn 37:472–475CrossRef
10.
Zurück zum Zitat Pentimone F, Riccioni S, Del Corso L (1999) Congenital hypopituitarism in a 48-year old adult. Natural course, hormonal study and MRI evidence. Minerva Endocrinol 24:87–90PubMed Pentimone F, Riccioni S, Del Corso L (1999) Congenital hypopituitarism in a 48-year old adult. Natural course, hormonal study and MRI evidence. Minerva Endocrinol 24:87–90PubMed
11.
Zurück zum Zitat Wada S, Minagawa A, Imamaki K et al (2000) A patient of hypogonadotropic hypogonadism accompanied by growth hormone deficiency and decreased bone mineral density who attained normal growth. Intern Med Tokyo Jpn 39:641–645CrossRef Wada S, Minagawa A, Imamaki K et al (2000) A patient of hypogonadotropic hypogonadism accompanied by growth hormone deficiency and decreased bone mineral density who attained normal growth. Intern Med Tokyo Jpn 39:641–645CrossRef
12.
Zurück zum Zitat Williams (1998) Textbook of endocrinology. Saunders, Philadelphia Williams (1998) Textbook of endocrinology. Saunders, Philadelphia
Metadaten
Titel
Delayed diagnosis of congenital hypopituitarism associated with low socio-economic status and/or migration
verfasst von
Emese Boros
Madeleine Casimir
Claudine Heinrichs
Cécile Brachet
Publikationsdatum
06.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 1/2020
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-019-03489-3

Neu im Fachgebiet Pädiatrie

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Medikamente verändern wohl Nährstoffzusammensetzung der Muttermilch

Einige Medikamente wie selektive Serotonin-Wiederaufnahmehemmer können offenbar die Makronährstoffzusammensetzung der Muttermilch verändern. Das birgt möglicherweise gesundheitliche Risiken für manche gestillte Kinder.

Kann man Gestationsdiabetes mit oralen Antidiabetika behandeln?

Der Wunsch, Frauen mit Gestationsdiabetes eine orale Erstlinientherapie anbieten zu können, bleibt auch vorläufig ein Wunsch: Eine orale Stufentherapie hat sich in einer randomisierten Studie nicht als gleichwertig zu einer Insulintherapie erwiesen. 

Frühwarnzeichen für multiple Sklerose bei Kindern und Jugendlichen

Ein Forschungsteam aus Deutschland und Kanada hat eine Reihe metabolischer, okulärer, muskuloskelettaler, gastrointestinaler und kardiovaskulärer Symptome identifiziert, die bei Kindern und Jugendlichen der Diagnose einer multiplen Sklerose (MS) vorausgehen können.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.